Veltuzumab
Veltuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Veltuzumab is a monoclonal antibody which, as of October 2009, is undergoing Phase I/II clinical trials for the treatment of non-Hodgkin's lymphoma.
Trade Name | Veltuzumab |
Generic | Veltuzumab |
Veltuzumab Other Names | Veltuzumab |
Type | |
Formula | C6458H9918N1706O2026S46 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in lymphoma (non-hodgkin's).
Innovators Monograph
You find simplified version here Veltuzumab